AstraZeneca
Judge Rules Against Drugmaker in Price Negotiation Lawsuit
2024-03-04 16:57:13
by
Dan McCue
WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a case challenging the constitutionality of Medicare’s new drug negotiation program. The case is one of several filed by the pharmaceutical... Read More
Straight From The Well
